Decreased Thioredoxin-1 and Increased HSP90 Expression in Skeletal Muscle in Subjects with Type 2 Diabetes or Impaired Glucose Tolerance
In diabetes, the endogenous defence systems are overwhelmed, causing various types of stress in tissues. In this study, newly diagnosed or diet-treated type 2 diabetics (T2D) (n=10) were compared with subjects with impaired glucose tolerance (IGT) (n=8). In both groups, at resting conditions, blood...
Gespeichert in:
Veröffentlicht in: | BioMed research international 2014-01, Vol.2014 (2014), p.1-6 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 6 |
---|---|
container_issue | 2014 |
container_start_page | 1 |
container_title | BioMed research international |
container_volume | 2014 |
creator | Venojärvi, M. Korkmaz, A. Aunola, S. Hällsten, K. Virtanen, K. Marniemi, J. Halonen, J.-P. Hänninen, O. Nuutila, P. Atalay, M. |
description | In diabetes, the endogenous defence systems are overwhelmed, causing various types of stress in tissues. In this study, newly diagnosed or diet-treated type 2 diabetics (T2D) (n=10) were compared with subjects with impaired glucose tolerance (IGT) (n=8). In both groups, at resting conditions, blood samples were drawn for assessing metabolic indices and skeletal muscle samples (m. vastus lateralis) were taken for the measurements of cellular defence markers: thioredoxin-1 (TRX-1) and stress proteins HSP72, HSP90. The protein level of TRX-1 was 36.1% lower (P=0.031) and HSP90 was 380% higher (P |
doi_str_mv | 10.1155/2014/386351 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3932292</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A427022850</galeid><sourcerecordid>A427022850</sourcerecordid><originalsourceid>FETCH-LOGICAL-c527t-a37433e8c2864716db7447ec081d09333308e48b5d53b5c91843ec1da16ba23c3</originalsourceid><addsrcrecordid>eNqNkktv1DAURiMEolXpijXIEhsECvUrjrNBqtrSjlQEUoe15Th3Oh48dmontP0H_dn1kHZ4bMAbW75Hx75XX1G8JPgDIVV1QDHhB0wKVpEnxS5lhJeCcPJ0e2Zsp9hPaYXzkkTgRjwvdigXssFM7hZ3x2Ai6AQdmi9tiNCFG-tLgrTv0Mw_1s4uvjYYndz0EVKywSPr0cV3cDBohz6PyTj4eTW2KzBDQtd2WKL5bQ-IomOrWxggoRDRbN1rmx9Bp240IQGaBwdRewMvimcL7RLsP-x7xbdPJ_Ojs_L8y-ns6PC8NBWth1KzmjMG0lApeE1E19ac12Bybx1uWF5YApdt1VWsrUxDJGdgSKeJaDVlhu0VHydvP7Zr6Az4IWqn-mjXOt6qoK36s-LtUl2GH4o1jNKGZsHbB0EMVyOkQa1tMuCc9hDGpEjFuKQUM_IfKKGUCoZxRt_8ha7CGH2eRKZwNsqs_UVdagfK-kXIXzQbqTrktMaUymrjej9RJoaUIiy23RGsNqlRm9SoKTWZfv37QLbsY0Yy8G4CltZ3-tr-w_ZqgiEjsNBbONswEeweFuvQXg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1503488534</pqid></control><display><type>article</type><title>Decreased Thioredoxin-1 and Increased HSP90 Expression in Skeletal Muscle in Subjects with Type 2 Diabetes or Impaired Glucose Tolerance</title><source>MEDLINE</source><source>PubMed Central Open Access</source><source>Wiley-Blackwell Open Access Titles</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Venojärvi, M. ; Korkmaz, A. ; Aunola, S. ; Hällsten, K. ; Virtanen, K. ; Marniemi, J. ; Halonen, J.-P. ; Hänninen, O. ; Nuutila, P. ; Atalay, M.</creator><contributor>Kushnir, Mark M.</contributor><creatorcontrib>Venojärvi, M. ; Korkmaz, A. ; Aunola, S. ; Hällsten, K. ; Virtanen, K. ; Marniemi, J. ; Halonen, J.-P. ; Hänninen, O. ; Nuutila, P. ; Atalay, M. ; Kushnir, Mark M.</creatorcontrib><description>In diabetes, the endogenous defence systems are overwhelmed, causing various types of stress in tissues. In this study, newly diagnosed or diet-treated type 2 diabetics (T2D) (n=10) were compared with subjects with impaired glucose tolerance (IGT) (n=8). In both groups, at resting conditions, blood samples were drawn for assessing metabolic indices and skeletal muscle samples (m. vastus lateralis) were taken for the measurements of cellular defence markers: thioredoxin-1 (TRX-1) and stress proteins HSP72, HSP90. The protein level of TRX-1 was 36.1% lower (P=0.031) and HSP90 was 380% higher (P<0.001) in the T2D than in the IGT subjects, with no significant changes in HSP72. However, after the adjustment of both analyses with HOMA-IR only HSP90 difference remained significant. In conclusion, level of TRX-1 in skeletal muscle tissue was lower while that of HSP90 was higher in T2D than in IGT subjects. This may impair antioxidant defence and lead to disruptions of protein homoeostasis and redox regulation of cellular defences. Because HSP90 may be involved in sustaining functional insulin signalling pathway in type 2 diabetic muscles and higher HSP90 levels can be a consequence of type 2 diabetes, our results are potentially important for the diabetes research.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2014/386351</identifier><identifier>PMID: 24689038</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Puplishing Corporation</publisher><subject>Biomedical research ; Blood Glucose - metabolism ; Diabetes Mellitus, Type 2 - metabolism ; Diabetes Mellitus, Type 2 - pathology ; Female ; Glucose ; Glucose intolerance ; Glucose Intolerance - metabolism ; Glucose Intolerance - pathology ; Health aspects ; Heat shock proteins ; HSP72 Heat-Shock Proteins - metabolism ; HSP90 Heat-Shock Proteins - metabolism ; Humans ; Insulin ; Kinases ; Male ; Middle Aged ; Muscle, Skeletal - metabolism ; Muscle, Skeletal - pathology ; Muscles ; Muscular system ; Physiological aspects ; Rodents ; Thioredoxin ; Thioredoxins - metabolism ; Type 2 diabetes</subject><ispartof>BioMed research international, 2014-01, Vol.2014 (2014), p.1-6</ispartof><rights>Copyright © 2014 M. Venojärvi et al.</rights><rights>COPYRIGHT 2014 John Wiley & Sons, Inc.</rights><rights>Copyright © 2014 M. Venojärvi et al. M. Venojärvi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2014 M. Venojärvi et al. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c527t-a37433e8c2864716db7447ec081d09333308e48b5d53b5c91843ec1da16ba23c3</citedby><cites>FETCH-LOGICAL-c527t-a37433e8c2864716db7447ec081d09333308e48b5d53b5c91843ec1da16ba23c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932292/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932292/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24689038$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Kushnir, Mark M.</contributor><creatorcontrib>Venojärvi, M.</creatorcontrib><creatorcontrib>Korkmaz, A.</creatorcontrib><creatorcontrib>Aunola, S.</creatorcontrib><creatorcontrib>Hällsten, K.</creatorcontrib><creatorcontrib>Virtanen, K.</creatorcontrib><creatorcontrib>Marniemi, J.</creatorcontrib><creatorcontrib>Halonen, J.-P.</creatorcontrib><creatorcontrib>Hänninen, O.</creatorcontrib><creatorcontrib>Nuutila, P.</creatorcontrib><creatorcontrib>Atalay, M.</creatorcontrib><title>Decreased Thioredoxin-1 and Increased HSP90 Expression in Skeletal Muscle in Subjects with Type 2 Diabetes or Impaired Glucose Tolerance</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>In diabetes, the endogenous defence systems are overwhelmed, causing various types of stress in tissues. In this study, newly diagnosed or diet-treated type 2 diabetics (T2D) (n=10) were compared with subjects with impaired glucose tolerance (IGT) (n=8). In both groups, at resting conditions, blood samples were drawn for assessing metabolic indices and skeletal muscle samples (m. vastus lateralis) were taken for the measurements of cellular defence markers: thioredoxin-1 (TRX-1) and stress proteins HSP72, HSP90. The protein level of TRX-1 was 36.1% lower (P=0.031) and HSP90 was 380% higher (P<0.001) in the T2D than in the IGT subjects, with no significant changes in HSP72. However, after the adjustment of both analyses with HOMA-IR only HSP90 difference remained significant. In conclusion, level of TRX-1 in skeletal muscle tissue was lower while that of HSP90 was higher in T2D than in IGT subjects. This may impair antioxidant defence and lead to disruptions of protein homoeostasis and redox regulation of cellular defences. Because HSP90 may be involved in sustaining functional insulin signalling pathway in type 2 diabetic muscles and higher HSP90 levels can be a consequence of type 2 diabetes, our results are potentially important for the diabetes research.</description><subject>Biomedical research</subject><subject>Blood Glucose - metabolism</subject><subject>Diabetes Mellitus, Type 2 - metabolism</subject><subject>Diabetes Mellitus, Type 2 - pathology</subject><subject>Female</subject><subject>Glucose</subject><subject>Glucose intolerance</subject><subject>Glucose Intolerance - metabolism</subject><subject>Glucose Intolerance - pathology</subject><subject>Health aspects</subject><subject>Heat shock proteins</subject><subject>HSP72 Heat-Shock Proteins - metabolism</subject><subject>HSP90 Heat-Shock Proteins - metabolism</subject><subject>Humans</subject><subject>Insulin</subject><subject>Kinases</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Muscle, Skeletal - metabolism</subject><subject>Muscle, Skeletal - pathology</subject><subject>Muscles</subject><subject>Muscular system</subject><subject>Physiological aspects</subject><subject>Rodents</subject><subject>Thioredoxin</subject><subject>Thioredoxins - metabolism</subject><subject>Type 2 diabetes</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkktv1DAURiMEolXpijXIEhsECvUrjrNBqtrSjlQEUoe15Th3Oh48dmontP0H_dn1kHZ4bMAbW75Hx75XX1G8JPgDIVV1QDHhB0wKVpEnxS5lhJeCcPJ0e2Zsp9hPaYXzkkTgRjwvdigXssFM7hZ3x2Ai6AQdmi9tiNCFG-tLgrTv0Mw_1s4uvjYYndz0EVKywSPr0cV3cDBohz6PyTj4eTW2KzBDQtd2WKL5bQ-IomOrWxggoRDRbN1rmx9Bp240IQGaBwdRewMvimcL7RLsP-x7xbdPJ_Ojs_L8y-ns6PC8NBWth1KzmjMG0lApeE1E19ac12Bybx1uWF5YApdt1VWsrUxDJGdgSKeJaDVlhu0VHydvP7Zr6Az4IWqn-mjXOt6qoK36s-LtUl2GH4o1jNKGZsHbB0EMVyOkQa1tMuCc9hDGpEjFuKQUM_IfKKGUCoZxRt_8ha7CGH2eRKZwNsqs_UVdagfK-kXIXzQbqTrktMaUymrjej9RJoaUIiy23RGsNqlRm9SoKTWZfv37QLbsY0Yy8G4CltZ3-tr-w_ZqgiEjsNBbONswEeweFuvQXg</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Venojärvi, M.</creator><creator>Korkmaz, A.</creator><creator>Aunola, S.</creator><creator>Hällsten, K.</creator><creator>Virtanen, K.</creator><creator>Marniemi, J.</creator><creator>Halonen, J.-P.</creator><creator>Hänninen, O.</creator><creator>Nuutila, P.</creator><creator>Atalay, M.</creator><general>Hindawi Puplishing Corporation</general><general>Hindawi Publishing Corporation</general><general>John Wiley & Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140101</creationdate><title>Decreased Thioredoxin-1 and Increased HSP90 Expression in Skeletal Muscle in Subjects with Type 2 Diabetes or Impaired Glucose Tolerance</title><author>Venojärvi, M. ; Korkmaz, A. ; Aunola, S. ; Hällsten, K. ; Virtanen, K. ; Marniemi, J. ; Halonen, J.-P. ; Hänninen, O. ; Nuutila, P. ; Atalay, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c527t-a37433e8c2864716db7447ec081d09333308e48b5d53b5c91843ec1da16ba23c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Biomedical research</topic><topic>Blood Glucose - metabolism</topic><topic>Diabetes Mellitus, Type 2 - metabolism</topic><topic>Diabetes Mellitus, Type 2 - pathology</topic><topic>Female</topic><topic>Glucose</topic><topic>Glucose intolerance</topic><topic>Glucose Intolerance - metabolism</topic><topic>Glucose Intolerance - pathology</topic><topic>Health aspects</topic><topic>Heat shock proteins</topic><topic>HSP72 Heat-Shock Proteins - metabolism</topic><topic>HSP90 Heat-Shock Proteins - metabolism</topic><topic>Humans</topic><topic>Insulin</topic><topic>Kinases</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Muscle, Skeletal - metabolism</topic><topic>Muscle, Skeletal - pathology</topic><topic>Muscles</topic><topic>Muscular system</topic><topic>Physiological aspects</topic><topic>Rodents</topic><topic>Thioredoxin</topic><topic>Thioredoxins - metabolism</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Venojärvi, M.</creatorcontrib><creatorcontrib>Korkmaz, A.</creatorcontrib><creatorcontrib>Aunola, S.</creatorcontrib><creatorcontrib>Hällsten, K.</creatorcontrib><creatorcontrib>Virtanen, K.</creatorcontrib><creatorcontrib>Marniemi, J.</creatorcontrib><creatorcontrib>Halonen, J.-P.</creatorcontrib><creatorcontrib>Hänninen, O.</creatorcontrib><creatorcontrib>Nuutila, P.</creatorcontrib><creatorcontrib>Atalay, M.</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Venojärvi, M.</au><au>Korkmaz, A.</au><au>Aunola, S.</au><au>Hällsten, K.</au><au>Virtanen, K.</au><au>Marniemi, J.</au><au>Halonen, J.-P.</au><au>Hänninen, O.</au><au>Nuutila, P.</au><au>Atalay, M.</au><au>Kushnir, Mark M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decreased Thioredoxin-1 and Increased HSP90 Expression in Skeletal Muscle in Subjects with Type 2 Diabetes or Impaired Glucose Tolerance</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2014-01-01</date><risdate>2014</risdate><volume>2014</volume><issue>2014</issue><spage>1</spage><epage>6</epage><pages>1-6</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>In diabetes, the endogenous defence systems are overwhelmed, causing various types of stress in tissues. In this study, newly diagnosed or diet-treated type 2 diabetics (T2D) (n=10) were compared with subjects with impaired glucose tolerance (IGT) (n=8). In both groups, at resting conditions, blood samples were drawn for assessing metabolic indices and skeletal muscle samples (m. vastus lateralis) were taken for the measurements of cellular defence markers: thioredoxin-1 (TRX-1) and stress proteins HSP72, HSP90. The protein level of TRX-1 was 36.1% lower (P=0.031) and HSP90 was 380% higher (P<0.001) in the T2D than in the IGT subjects, with no significant changes in HSP72. However, after the adjustment of both analyses with HOMA-IR only HSP90 difference remained significant. In conclusion, level of TRX-1 in skeletal muscle tissue was lower while that of HSP90 was higher in T2D than in IGT subjects. This may impair antioxidant defence and lead to disruptions of protein homoeostasis and redox regulation of cellular defences. Because HSP90 may be involved in sustaining functional insulin signalling pathway in type 2 diabetic muscles and higher HSP90 levels can be a consequence of type 2 diabetes, our results are potentially important for the diabetes research.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Puplishing Corporation</pub><pmid>24689038</pmid><doi>10.1155/2014/386351</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2314-6133 |
ispartof | BioMed research international, 2014-01, Vol.2014 (2014), p.1-6 |
issn | 2314-6133 2314-6141 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3932292 |
source | MEDLINE; PubMed Central Open Access; Wiley-Blackwell Open Access Titles; PubMed Central; Alma/SFX Local Collection |
subjects | Biomedical research Blood Glucose - metabolism Diabetes Mellitus, Type 2 - metabolism Diabetes Mellitus, Type 2 - pathology Female Glucose Glucose intolerance Glucose Intolerance - metabolism Glucose Intolerance - pathology Health aspects Heat shock proteins HSP72 Heat-Shock Proteins - metabolism HSP90 Heat-Shock Proteins - metabolism Humans Insulin Kinases Male Middle Aged Muscle, Skeletal - metabolism Muscle, Skeletal - pathology Muscles Muscular system Physiological aspects Rodents Thioredoxin Thioredoxins - metabolism Type 2 diabetes |
title | Decreased Thioredoxin-1 and Increased HSP90 Expression in Skeletal Muscle in Subjects with Type 2 Diabetes or Impaired Glucose Tolerance |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T15%3A10%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decreased%20Thioredoxin-1%20and%20Increased%20HSP90%20Expression%20in%20Skeletal%20Muscle%20in%20Subjects%20with%20Type%202%20Diabetes%20or%20Impaired%20Glucose%20Tolerance&rft.jtitle=BioMed%20research%20international&rft.au=Venoj%C3%A4rvi,%20M.&rft.date=2014-01-01&rft.volume=2014&rft.issue=2014&rft.spage=1&rft.epage=6&rft.pages=1-6&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2014/386351&rft_dat=%3Cgale_pubme%3EA427022850%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1503488534&rft_id=info:pmid/24689038&rft_galeid=A427022850&rfr_iscdi=true |